Triple therapy for asthma containing long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and inhaled corticosteroid (ICS) is a newer option for asthma management, especially when all three components are combined in a single inhaler (SITT: single-inhaler triple therapy), which promotes better adherence than multiple inhalers. There are questions as to its efficacy beyond the ICS/LABA combination, and evidence certainly shows that it will improve lung function, decrease exacerbations, and potentially help with symptoms. Global Initiative for Asthma (GINA) suggests these are Step 5 therapies, as they add on to medium-dose ICS/LABA. Fortunately, these compounds are quite safe and well tolerated. GINA recommendations for Step 5 will be reviewed, including particularly the place for LAMA addition as add-on therapy to ICS/LABA, and novel potential clinical applications will be reviewed.
Dual vs. Triple Therapy in Asthma: Are We Ready to Move Beyond ICS-LABA?. // The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. – 2026. – DOI: 10.1007/s41030-026-00390-x. – URL: https://link.springer.com/article/10.1007/s41030-026-00390-x
(2026). Dual vs. Triple Therapy in Asthma: Are We Ready to Move Beyond ICS-LABA?. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. https://doi.org/10.1007/s41030-026-00390-x
“Dual vs. Triple Therapy in Asthma: Are We Ready to Move Beyond ICS-LABA?.” The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2026. doi:10.1007/s41030-026-00390-x.
@article{article35056,
title = {Dual vs. Triple Therapy in Asthma: Are We Ready to Move Beyond ICS-LABA?},
journal = {The Egyptian Journal of Neurology, Psychiatry and Neurosurgery},
year = {2026},
doi = {10.1007/s41030-026-00390-x},
url = {https://link.springer.com/article/10.1007/s41030-026-00390-x}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....